These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 19678494

  • 1. [How effectively should hyperglycemia be treated in a type 2 diabetes patient?].
    Eriksson J.
    Duodecim; 2009; 125(13):1387-94. PubMed ID: 19678494
    [Abstract] [Full Text] [Related]

  • 2. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes.
    Riccardi G.
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):104-7. PubMed ID: 11006917
    [No Abstract] [Full Text] [Related]

  • 3. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA, Valiquette G, Schwarcz MD.
    Cardiol Rev; 2009 Jun; 17(4):165-75. PubMed ID: 19525678
    [Abstract] [Full Text] [Related]

  • 4. Type 2 diabetes and cardiovascular risk factors.
    Sharma MD, Farmer JA, Garber A.
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():1-5. PubMed ID: 22106974
    [Abstract] [Full Text] [Related]

  • 5. Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials.
    Soo Yeon S, Nesto RW.
    Rev Cardiovasc Med; 2008 Nov; 9(1):1-4. PubMed ID: 18418304
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation?
    Gerstein HC, Rosenstock J.
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):137-54. PubMed ID: 15752926
    [Abstract] [Full Text] [Related]

  • 10. UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes.
    Adler AI.
    Diabet Med; 2008 Aug; 25 Suppl 2():41-6. PubMed ID: 18717978
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S.
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin resistance syndrome and glucose dysregulation in the elderly.
    Mazza AD.
    Clin Geriatr Med; 2008 Aug; 24(3):437-54, vi. PubMed ID: 18672181
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperglycemia and cardiovascular disease in type 2 diabetes.
    Laakso M.
    Diabetes; 1999 May; 48(5):937-42. PubMed ID: 10331395
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
    Seufert J.
    Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.